Clin2
NCT06860659Possibly a fitEnrolling by invitation

Hyaluronate eye drops for moderate to severe dry eye

Dry Eye Disease (DED)Tear Break-Up TimeTear DisorderTear Film InsufficiencyTear Film HyperosmolarityDry EyeHyaluronateHyaluronic Acid

Part of Eyes & vision clinical trials.

This trial tests whether 0.28% sodium hyaluronate eye drops can help people with moderate to severe dry eye feel better. It's for patients who have significant dry eye symptoms and signs on an eye exam.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
84 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have moderate to severe dry eye symptoms (a score of 23 or higher on the OSDI questionnaire)
  • Your dry eye is confirmed by an eye exam (Oxford grade 2 or higher, and a tear break-up time less than 7 seconds)
  • You are not allergic to sodium hyaluronate
  • You do not have other eye diseases needing separate treatment (like glaucoma), and you haven't had eye surgery in the last 3 months or laser vision correction in the last 6 months
  • You do not wear contact lenses, are not pregnant or breastfeeding, and do not have uncontrolled medical conditions like diabetes or autoimmune disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT07412860Recruiting
Eye drop test for moderate to severe dry eye

This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.

Cagliari, CA
NCT07679685Not yet recruiting· Phase 4
Comparing Two Eye Drops for Screen-Related Dry Eye

This trial tests two different types of eye drops for people with dry eyes that are linked to lots of screen time. It compares a new eye drop (perfluorohexyloctane) to a common one (sodium hyaluronate) to see which works better for screen-related dry eye.

Beijing, Beijing Municipality
NCT07656688Recruiting· Phase 2
Finding the best dose for a dry eye treatment

This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.

Seoul
NCT06633471Not yet recruiting· Early Phase 1
Evaluating a new artificial tear for dry eye disease

This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.

Bridgetown
NCT07745062Recruiting· Phase 4
Comparing two eye drops for mild to moderate dry eye

This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.

La Jolla, California

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.